Articles

1. Intravenous Immunoglobulins in Idiopathic Inflammatory Myopathies: Where Are We?

   • Kevin Gourbeyre-Masson
   • Océane Landon-Cardinal
   • Yves Allenbach

   Other CTD: Inflammatory Myopathies (J Milisenda, Section Editor) 10 January 2024 Pages: 1 - 23

2. Treatment of Myositis Associated With Immune Checkpoint Inhibitors

   • Ana Matas-García
   • Eugenia Martinez-Hernandez
   • José César Milisenda

   Other CTD: Inflammatory Myopathies (K Saag, Section Editor) 02 November 2023 Pages: 179 - 191

   

3. Molecular Mechanisms Underlying Systemic Sclerosis–Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: an Update

   • Priyanka Verma
   • Swarna Bale
   • Swati Bhattacharyya

   Role of Metabolism in Fibrosis: Translational Implications (K Saag, Section Editor) 18 October 2023 Pages: 221 - 235

   

4. Mitochondrial DNA-Sensing Pathogen Recognition Receptors in Systemic Sclerosis-Associated Interstitial Lung Disease: a Review

   • Alexander Ghincea
   • Samuel Woo
   • Changwan Ryu

   Role of Metabolism in Fibrosis: Translational Implications (S Bhattacharyya, Section Editor) Open access 08 August 2023 Pages: 204 - 220

   

5. The Greater Trochanteric Pain Syndrome: Clinical Presentation, Diagnosis, and Management

   • Romain Guemara
   • Michael John Nissen

   Pain in Rheumatology (M Harth, Section Editor) Open access 08 August 2023 Pages: 192 - 203

   

6. Systemic Sclerosis-Associated Myopathy: How to Treat

   • A. Selva-O’Callaghan
   • A. Guillen-Del-Castillo
   • C. Simeón-Aznar

   Other CTD: Inflammatory Myopathies (J Milisenda, Section Editor) 19 July 2023 Pages: 151 - 167

   

7. Treatment of Immune-Mediated Necrotizing Myopathy

   • Sandra Amara Ogbonnaya-Whittlesey
   • Dale Kobrin
   • Iago Pinal-Fernandez

   Other CTD: Inflammatory Myopathies (J Milisenda, Section Editor) 13 July 2023 Pages: 168 - 178

8. Intra-articular Therapies for Knee Osteoarthritis: Current Update

   • Win Min Oo
   • J Hunter

   Osteoarthritis (L King, Section Editor) Open access 01 July 2023 Pages: 99 - 119

9. Patient Preferences and Osteoarthritis Care: What Do We Know About What Patients Want from Osteoarthritis Treatment?

   • Philippa J A Nicolson
   • Melanie A Holden

   Osteoarthritis (L King, Section Editor) Open access 19 June 2023 Pages: 120 - 131

10. Exercise Therapy for Knee and Hip Osteoarthritis: Is There An Ideal Prescription?

    • James J. Young
    • Julie Rønne Pedersen
    • Alessio Bricca

    Osteoarthritis (L King, Section Editor) 20 May 2023 Pages: 82 - 98

11. Painful Knee Osteoarthritis and Radiofrequency Neurotomy of Genicular Nerves

    • E. Ertilav
    • S. Sari
    • O. N. Aydin

    Pain in Rheumatology (M Harth, Section Editor) 15 May 2023 Pages: 132 - 149

    

12. The Contribution of the Psychologist in the Assessment and Treatment of Fibromyalgia

    • Juan V. Luciano
    • Randy Neblett
    • Lance M. McCracken

    Pain in Rheumatology (M Harth, Section Editor) Open access 13 April 2023 Pages: 11 - 31

    

13. Intra-articular Mineralization and Association with Osteoarthritis Development and Outcomes

    • Jean W. Liew

    Osteoarthritis (L King, Section Editor) 05 April 2023 Pages: 70 - 81

    

14. Pathogenesis and Treatment in IMNM

    • Charles-Antoine Dallevet
    • Olivier Benveniste
    • Yves Allenbach

    Other CTD: Inflammatory Myopathies (J Milisenda, Section Editor) 22 March 2023 Pages: 32 - 48

    

15. Virtual Tools to Enable Management of Knee Osteoarthritis

    • Rana S. Hinman
    • Belinda J. Lawford
    • Kim L. Bennell

    Osteoarthritis (L King, Section Editor) Open access 11 March 2023 Pages: 49 - 69

16. An Unusual Presentation of ANCA-Negative Granulomatosis With Polyangiitis (GPA) in the Gynecological Tract and Literature Review

    • Arpita Gantayet
    • Paul Plantinga
    • Janet E. Pope

    Hot Topic 12 January 2023 Pages: 1 - 10

    

17. Management of Cancer-Associated Myositis

    • Albert Selva-O’Callaghan
    • Ernesto Trallero-Araguás
    • Iago Pinal-Fernandez

    Other CTD: Inflammatory Myopathies and Sjogren's (I Pinal-Fernández, Section Editor) 21 October 2022 Pages: 91 - 104

18. Utility of Myositis-Specific Autoantibodies for Treatment Selection in Myositis

    • Maria Casal-Dominguez
    • Iago Pinal-Fernández
    • Andrew L Mammen

    Other CTD: Inflammatory Myopathies and Sjogren's (I Pinal-Fernández, Section Editor) 28 September 2022 Pages: 105 - 116

    

19. Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

    • Alice Cole
    • Christopher P. Denton

    Scleroderma (Systemic Sclerosis) (S Bhattacharyya, Section Editor) Open access 24 September 2022 Pages: 152 - 170

    

20. Remote Management of Osteoporosis

    • Jordan L. Saag
    • Maria I. Danila

    Osteoporosis (K Saag, Section Editor) 02 September 2022 Pages: 143 - 151

21. Tailored Interventions for Supporting Physical Activity Participation in People with Arthritis and Related Conditions: a Systematic Review

    • Jasmin K. Ma
    • Smruthi Ramachandran
    • Linda C. Li

    Osteoarthritis (L King, Section Editor) 20 August 2022 Pages: 117 - 142

    

22. Past, Present, and Future in Dermatomyositis Therapeutics

    • Melody P. Chung
    • Julie J. Paik

    Other CTD: Inflammatory Myopathies and Sjogren's (I Pinal-Fernández, Section Editor) 26 July 2022 Pages: 71 - 90

23. Pros and Cons of Skeletal Medications in the COVID-19 Era

    • Elena Tsourdi
    • Matthew T. Drake

    Osteoporosis (K Saag, Section Editor) 16 July 2022 Pages: 56 - 69

24. Bisphosphonate Drug Holiday and Fracture Risk: Reviewing the Evidence

    • Annette L. Adams
    • Denison S. Ryan
    • Heidi Fischer

    Osteoporosis (K Saag, Section Editor) 06 July 2022 Pages: 37 - 55

25. The Effectiveness of Fracture Liaison Services in Improving Fragility Fracture Outcomes

    • Nitasha Khullar
    • Maria I. Danila

    Osteoporosis (K Saag, Section Editor) 31 March 2022 Pages: 19 - 35

26. Understanding and Therapeutically Targeting the Scleroderma Myofibroblast

    • Anthony Ocon
    • Sravani Lokineni
    • Benjamin Korman

    Scleroderma (S Bhattacharyya, Section Editor) 01 April 2022 Pages: 1 - 18

    

27. Insights Into the Preclinical Models of SSc

    • Yoshihide Asano

    Scleroderma (S Bhattacharyya, Section Editor) 08 November 2021 Pages: 334 - 348

    

28. Acute Sacroiliac Joint Pain: Clinical Presentation, Causes, and Investigations

    • R. Alkilany
    • M. Antonelli
    • M. N. Magrey

    Pain in Rheumatology (W Nielson and M Harth, Section Editors) 08 November 2021 Pages: 307 - 318

29. Dysregulation of Type I Interferon Signaling in Systemic Sclerosis: a Promising Therapeutic Target?

    • Minghua Wu
    • Shervin Assassi

    Scleroderma (S Bhattacharyya, Section Editor) 19 October 2021 Pages: 349 - 360

    

30. Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease

    • A. Selva-O’Callaghan
    • F. Romero-Bueno
    • I. Pinal-Fernández

    Other CTD: Inflammatory Myopathies and Sjogren’s (I Pinal-Fernandez, Section Editor) 28 September 2021 Pages: 319 - 333

    

31. Insights Into Systemic Sclerosis from Gene Expression Profiling

    • Jennifer M. Franks
    • Michael L. Whitfield

    Scleroderma (S Bhattacharyya, Section Editor) 20 August 2021 Pages: 208 - 221

    

32. Shoulder Pain — Where Are We Now?

    • Karen Walker-Bone
    • Danielle AWM van der Windt

    Pain in Rheumatology (W Nielson and M Harth, Section Editors) Open access 05 August 2021 Pages: 285 - 306

    

33. A Self-Report Multidimensional Health Assessment Questionnaire (MDHAQ) for Face-To-Face or Telemedicine Encounters to Assess Clinical Severity (RAPID3) and Screen for Fibromyalgia (FAST) and Depression (DEP)

    • Kathryn A. Gibson
    • Theodore Pincus

    Rheumatoid Arthritis (Y Yazici, Section Editor) Open access 28 July 2021 Pages: 161 - 181

    

34. Inhibiting Interferon Pathways in Dermatomyositis: Rationale and Preliminary Evidence

    • Maria Casal-Dominguez
    • Iago Pinal-Fernandez
    • Andrew L. Mammen

    Other CTD: Inflammatory Myopathies and Sjogren’s (P Basharat and JFL Albayda, Section Editors) 14 June 2021 Pages: 258 - 271

    

35. Consideration of Fibromyalgia in the Assessment and Treatment of SLE

    • William Fung
    • Zahi Touma

    Pain in Rheumatology (W Nielson and M Harth, Section Editors) 09 June 2021 Pages: 182 - 193

36. Adverse Events Associated with Belimumab Therapy in Systemic Lupus Erythematosus

    • Leong Tung Ong
    • Nicholas Ming Zher Chee

    Other CTD: Inflammatory Myopathies and Sjogren’s (P Basharat and JFL Albayda, Section Editors) 24 May 2021 Pages: 272 - 284

37. Clinical Trials in Myositis: Where Do We Stand?

    • Heřman Mann
    • Jiří Vencovský

    Other CTD: Inflammatory Myopathies and Sjogren’s (P Basharat and JFL Albayda, Section Editors) 21 May 2021 Pages: 222 - 242

38. Treatment in Antisynthetase Syndrome-Associated Interstitial Lung Disease

    • JA Huapaya
    • KD Wiley
    • SK Danoff

    Other CTD: Inflammatory Myopathies and Sjogren’s (P Basharat and JFL Albayda, Section Editors) 08 May 2021 Pages: 243 - 257

    

39. Mechanisms and Mediators of Pain in Chronic Inflammatory Arthritis

    • Marco Di Carlo
    • Gianluca Smerilli
    • Fausto Salaffi

    Other CTD: Inflammatory Myopathies and Sjogren’s (P Basharat and JFL Albayda, Section Editors) Open access 03 May 2021 Pages: 194 - 207

    

40. Update on Maintenance Therapies for ANCA-Associated Vasculitis

    • Christian Pagnoux
    • Aurore Fifi-Mah

    Vasculitis (L Barra, Section Editor) 29 April 2021 Pages: 112 - 133

    

41. Therapeutic Management of Immune-Mediated Necrotizing Myositis

    • Emma Weeding
    • Eleni Tiniakou

    Other CTD: Inflammatory Myopathies and Sjogren’s (P Basharat and JFL Albayda, Section Editors) 29 March 2021 Pages: 150 - 160

42. Updates in the Treatment of Rheumatoid Arthritis

    • Sarah A. Fantus
    • Eric M. Ruderman

    Rheumatoid Arthritis (Y Yazici, Section Editor) 22 March 2021 Pages: 99 - 111

    

43. Quantity and Quality of Rheumatoid Arthritis and Osteoarthritis Clinical Practice Guidelines: Systematic Review and Assessment Using AGREE II

    • Jeremy Y. Ng
    • Ashlee M. Azizudin

    Other CTD: Inflammatory Myopathies and Sjogren’s (P Basharat and JFL Albayda, Section Editors) 26 February 2021 Pages: 134 - 149

    

44. Evaluation and Treatment of Pediatric Localized Scleroderma: Pearls and Updates

    • Daniel Glaser
    • Kathryn S. Torok

    Scleroderma (S Bhattacharyya, Section Editor) 13 February 2021 Pages: 1 - 20

    

45. Soluble Biomarkers for Prediction of Vascular and Gastrointestinal Disease Severity in Patients with Systemic Sclerosis

    • Miruna Carnaru
    • Monique Hinchcliff

    Scleroderma (S Bhattacharyya, Section Editor) 11 February 2021 Pages: 21 - 38

    

46. In Pursuit of an Effective Treatment: the Past, Present and Future of Clinical Trials in Inclusion Body Myositis

    • A. M. Snedden
    • J. B. Lilleker
    • H. Chinoy

    Other CTD: Inflammatory Myopathies and Sjogren’s (P Basharat and JFL Albayda, Section Editors) Open access 09 February 2021 Pages: 63 - 81

    

47. Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy

    • Lauren M. Pachman
    • Brian E. Nolan
    • Amer M. Khojah

    Pediatric Rheumatology (G Martini, Section Editor) Open access 06 February 2021 Pages: 39 - 62

    

48. Non-infectious Chronic Uveitis in Childhood: Assessment and Treatment in the Biological Era

    • Roberta Ponti
    • Maria Vincenza Mastrolia
    • Gabriele Simonini

    Other CTD: Inflammatory Myopathies and Sjogren’s (P Basharat and JFL Albayda, Section Editors) 06 January 2021 Pages: 82 - 97

    

49. An Update on Imaging in Rheumatoid Arthritis

    • Maxine Isbel
    • Shereen Paramalingam
    • Helen I. Keen

    Rheumatoid Arthritis (Y Yazici, Section Editor) 13 November 2020 Pages: 370 - 381

50. Current Therapeutic Approaches in Scleroderma: Clinical Models of Effective Antifibrotic Therapies

    • Sindhu R. Johnson
    • Daniel E. Furst

    Scleroderma (S Bhattacharyya, Section Editor) 08 November 2020 Pages: 382 - 393